Status:
UNKNOWN
Endoscopy Assisted Probing Versus Simple Probing in Primary Congenital Nasolacrimal Duct Obstruction
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Congenital Nasolacrimal Duct Obstruction
Eligibility:
All Genders
3-6 years
Phase:
NA
Brief Summary
The aim of this study is to compare results of endoscopy assisted nasolacrimal probing with the standard simple probing in cases with congenital nasolacrimal duct obstruction . Furthermore, investigat...
Detailed Description
Congenital nasolacrimal duct obstruction is the most common cause of epiphora in infancy that can occur in 5% of newborn infants. It may resolve spontaneously in 95% of patients during the first year ...
Eligibility Criteria
Inclusion
- age: 3 weeks\<Age\<6 years
- epiphora or discharge since birth or within 8 weeks after birth
Exclusion
- Follow up less than 3 months
- Epiphora secondary to etiologies than congenital naso-lacrimal duct obstruction such as puncta/canalicular aplasia/dysgenesis;midfacial anomalies; congenital eyelid malposition;epiblepharon; trichiasis; congenital glaucoma, tumors; blepharitis; trauma Treatment success: defined success absence of epiphora/lacrimation and discharge 6 months after intervention.
Key Trial Info
Start Date :
July 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2020
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT03242681
Start Date
July 20 2017
End Date
July 1 2020
Last Update
October 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Farzad Pakdel
Tehran, Iran